Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Lymphoma 25Leukemia 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Breast Neoplasms 16Leukemia, Myeloid, Acute 15Lymphoma, Non-Hodgkin 14Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Multiple Myeloma 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma, B-Cell, Marginal Zone 10Leukemia, Myeloid, Chronic-Phase 10Neuroblastoma 9Myelodysplastic Syndromes 9Hodgkin Disease 9Congenital Abnormalities 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Myeloproliferative Disorders 7Central Nervous System Neoplasms 7Blast Crisis 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Polycythemia Vera 5

Interventions

Lenalidomide 2Watchful Waiting 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Observation 1Melphalan 1Celecoxib 1AH 111585 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Smoldering Multiple Myeloma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00114101 2026-05-29

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

National Cancer Institute (NCI)

Phase 3 Active not recruiting
460 enrolled 11 charts
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡